Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy.
Javaugue V, Dufour-Nourigat L, Desport E, Sibille A, Moulin B, Bataille P, Bindi P, Garrouste C, Mariat C, Karlin L, Nouvier M, Goujon JM, Gnemmi V, Fermand JP, Touchard G, Bridoux F.
Javaugue V, et al. Among authors: bindi p.
Kidney Int. 2021 Feb;99(2):421-430. doi: 10.1016/j.kint.2020.06.039. Epub 2020 Jul 30.
Kidney Int. 2021.
PMID: 32739419